F D C Ltd
FDCF D C Ltd
FDC
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 25.81 | 3.90 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
FDC Limited is a pharmaceutical company engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,032.86 | 1,064.15 | 1,126.03 | 1,134.17 | 1,413.09 | 1,430.24 | 1,604.01 | 1,833.61 | 2,044.57 | 2,180.43 | ||||||||||
Raw Materials | 363.25 | 340.29 | 354.77 | 367.29 | 420.53 | 440.17 | 595.64 | 670.93 | 709.63 | 1,715.43 | ||||||||||
| Power & Fuel Cost | 23.14 | 21.55 | 22.00 | 24.61 | 27.40 | 27.08 | 28.92 | 34.12 | 37.38 | |||||||||||
| Employee Cost | 175.76 | 191.08 | 216.67 | 225.57 | 277.48 | 296.29 | 343.33 | 390.90 | 413.40 | |||||||||||
| Selling & Administrative Expenses | 108.33 | 117.71 | 137.51 | 138.37 | 160.43 | 156.64 | 234.10 | 289.12 | 312.99 | |||||||||||
| Operating & Other expenses | 95.11 | 105.66 | 117.91 | 107.01 | 166.41 | 81.10 | 72.24 | 147.71 | 131.01 | |||||||||||
EBITDA | 267.27 | 287.86 | 277.17 | 271.32 | 360.84 | 428.96 | 329.78 | 300.83 | 440.16 | 465.00 | ||||||||||
| Depreciation/Amortization | 33.73 | 34.62 | 35.14 | 33.24 | 37.46 | 37.81 | 37.30 | 38.94 | 39.92 | 45.22 | ||||||||||
| PBIT | 233.54 | 253.24 | 242.03 | 238.08 | 323.38 | 391.15 | 292.48 | 261.89 | 400.24 | 419.78 | ||||||||||
| Interest & Other Items | 1.40 | 1.41 | 1.40 | 1.44 | 3.42 | 3.43 | 3.09 | 4.09 | 4.03 | 4.29 | ||||||||||
| PBT | 232.14 | 251.83 | 240.63 | 236.64 | 319.96 | 387.72 | 289.39 | 257.80 | 396.21 | 415.49 | ||||||||||
| Taxes & Other Items | 63.47 | 63.30 | 67.12 | 66.84 | 80.07 | 86.37 | 72.99 | 63.76 | 91.00 | 98.89 | ||||||||||
| Net Income | 168.67 | 188.53 | 173.51 | 169.80 | 239.89 | 301.35 | 216.40 | 194.04 | 305.21 | 316.60 | ||||||||||
| EPS | 9.32 | 10.42 | 9.68 | 9.56 | 13.77 | 17.74 | 12.82 | 11.59 | 18.57 | 19.45 | ||||||||||
| DPS | 2.25 | 2.25 | 0.00 | 0.00 | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.24 | 0.22 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| F D C Ltd | 26.78 | 3.90 | — |
| Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
| Cipla Ltd | 28.51 | 4.38 | 0.89% |
| Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare FDC with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding F D C Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.6657% | Percentage of the fund’s portfolio invested in the stock 0.35% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 76/234 (-31) |
ICICI Prudential Smallcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8541% | Percentage of the fund’s portfolio invested in the stock 0.83% | Change in the portfolio weight of the stock over the last 3 months -0.34% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 44/130 (-4) |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7499% | Percentage of the fund’s portfolio invested in the stock 1.21% | Change in the portfolio weight of the stock over the last 3 months -0.41% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 26/51 (-6) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateNov 22, 2024
Dividend/Share
₹5.00
Ex DateEx Date
Nov 22, 2024
Cash Dividend
Ex DateEx DateMar 19, 2020
Dividend/Share
₹0.80
Ex DateEx Date
Mar 19, 2020
Cash Dividend
Ex DateEx DateAug 8, 2017
Dividend/Share
₹2.25
Ex DateEx Date
Aug 8, 2017
Cash Dividend
Ex DateEx DateMar 17, 2016
Dividend/Share
₹2.25
Ex DateEx Date
Mar 17, 2016
Cash Dividend
Ex DateEx DateSep 23, 2015
Dividend/Share
₹2.25
Ex DateEx Date
Sep 23, 2015
FDC announced that the Board of Directors of the Company at its meeting held on 6 November 2024, inter alia, have recommended the first interim dividend of Rs 5 per equity Share (i.e. 500%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of FDC rose 3.18% to Rs 72.04 crore in the quarter ended September 2024 as against Rs 69.82 crore during the previous quarter ended September 2023. Sales rose 5.65% to Rs 513.85 crore in the quarter ended September 2024 as against Rs 486.37 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales513.85486.37 6 OPM %13.6515.71 - PBDT103.79102.60 1 PBT90.0092.73 -3 NP72.0469.82 3 Powered by Capital Market - Live
FDC will hold a meeting of the Board of Directors of the Company on 6 November 2024Powered by Capital Market - Live
Kaynes Technology India Ltd, Engineers India Ltd, Mrs Bectors Food Specialities Ltd and Varun Beverages Ltd are among the other gainers in the BSE's 'A' group today, 12 September 2024.FDC Ltd soared 10.82% to Rs 639.75 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 3.63 lakh shares were traded on the counter so far as against the average daily volumes of 30294 shares in the past one month. Kaynes Technology India Ltd spiked 6.79% to Rs 4976.3. The stock was the second biggest gainer in 'A' group. On the BSE, 18895 shares were traded on the counter so far as against the average daily volumes of 18212 shares in the past one month. Engineers India Ltd surged 5.87% to Rs 221.9. The stock was the third biggest gainer in 'A' group. On the BSE, 5.36 lakh shares were traded on the counter so far as against the average daily volumes of 3.5 lakh shares in the past one month. Mrs Bectors Food Specialities Ltd spurt 5.36% to Rs 1920. The stock was the fourth biggest gainer in 'A' group. On the BSE, 47524 shares were traded on the counter so far as against the average daily volumes of 18204 shares in the past one month. Varun Beverages Ltd exploded 5.14% to Rs 659.85. The stock was the fifth biggest gainer in 'A' group. On the BSE, 2.71 lakh shares were traded on the counter so far as against the average daily volumes of 1.26 lakh shares in the past one month. Powered by Capital Market - Live
FDC announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
FDC announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
Net profit of FDC rose 8.33% to Rs 119.04 crore in the quarter ended June 2024 as against Rs 109.89 crore during the previous quarter ended June 2023. Sales rose 19.00% to Rs 638.27 crore in the quarter ended June 2024 as against Rs 536.38 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales638.27536.38 19 OPM %22.9722.75 - PBDT173.76150.37 16 PBT162.73140.74 16 NP119.04109.89 8 Powered by Capital Market - Live
Technical Breakout Stocks: How to trade FDC, Bandhan Bank and Tata Motors on Tuesday? - Market Summary
Volumes spurt at FDC Ltd counter
FDC will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.51%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.52% to 0.54%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 12.44%, vs industry avg of 15.27%